|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.0348 USD | +8.75% |
|
+7.08% | +74.00% |
| Market Cap | 5.07M 3.58M 3.14M 2.89M 2.67M 342M 5.15M 34.55M 13.57M 168M 13.46M 13.16M 579M | P/E 2024 |
-6.82x | P/E 2025 | -2.84x |
|---|---|---|---|---|---|
| Enterprise Value | 9.47M 6.69M 5.86M 5.4M 4.99M 638M 9.62M 64.53M 25.34M 315M 25.14M 24.59M 1.08B | EV / Sales 2024 |
1.15x | EV / Sales 2025 | 0.85x |
| Free-Float |
89.84% | Yield 2024 * |
-
| Yield 2025 | - |
| 1 day | +8.75% | ||
| 1 week | +7.08% | ||
| Current month | +7.08% | ||
| 1 month | -10.77% | ||
| 3 months | +26.55% | ||
| 6 months | +16.78% | ||
| Current year | +74.00% |
| 1 week | 0.03 | 0.03 | |
| 1 month | 0.01 | 0.04 | |
| Current year | 0 | 0.07 | |
| 1 year | 0 | 0.07 | |
| 3 years | 0 | 0.18 | |
| 5 years | 0 | 0.4 | |
| 10 years | 0 | 2.6 |
| Manager | Title | Age | Since |
|---|---|---|---|
Taz Turner
CEO | Chief Executive Officer | - | 2017-09-21 |
Ashish Kapoor
DFI | Director of Finance/CFO | 48 | 2015-03-09 |
Graeme Hawkins
COO | Chief Operating Officer | - | - |
| Director | Title | Age | Since |
|---|---|---|---|
Taz Turner
CHM | Chairman | - | 2018-05-16 |
Benjamin Higham
BRD | Director/Board Member | - | 2020-04-07 |
Jakob Ripshtein
BRD | Director/Board Member | 59 | 2020-04-07 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 23-12-16 | Buy | Director | 30,000 | 0.0274% | ||
| 23-12-16 | Buy | Director | 500 | 0.0005% | ||
| 23-12-16 | Buy | Director | 500 | 0.0005% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
| +8.75% | +7.08% | -0.57% | -81.42% | 3.82M | ||
| -0.79% | -7.46% | +14.33% | -7.12% | 1.56B | ||
| +1.72% | -5.52% | +73.68% | +273.73% | 1B | ||
| -0.95% | -4.00% | -4.88% | +93.79% | 194M | ||
| 0.00% | -10.99% | +58.82% | -65.53% | 177M | ||
| -0.67% | -4.84% | +18.95% | -44.86% | 84.11M | ||
| Average | +1.34% | -5.47% | +26.72% | +28.10% | 503.46M | |
| Weighted average by Cap. | +0.10% | -6.72% | +35.56% | +88.20% |
| 2024 | 2025 | |
|---|---|---|
| Net sales | 13.8M 9.76M 8.54M 7.87M 7.27M 931M 14.03M 94.07M 36.94M 458M 36.64M 35.84M 1.58B | 14.25M 10.08M 8.81M 8.13M 7.51M 961M 14.49M 97.15M 38.15M 473M 37.84M 37.02M 1.63B |
| Net income | -1.49M -1.06M -923K -852K -787K -101M -1.52M -10.18M -4M -49.6M -3.96M -3.88M -171M | -2.69M -1.9M -1.66M -1.54M -1.42M -181M -2.74M -18.34M -7.2M -89.41M -7.15M -6.99M -307M |
| Net Debt | 5.66M 4M 3.5M 3.23M 2.98M 382M 5.75M 38.58M 15.15M 188M 15.03M 14.7M 646M | 4.4M 3.11M 2.72M 2.51M 2.32M 297M 4.47M 29.98M 11.77M 146M 11.68M 11.42M 502M |
Employees
-
Sector
Drug Retailers
| Date | Price | Change | Volume |
|---|---|---|---|
| 26-07-10 | US$0.0348 | +8.75% | 10,000 |
- Stock Market
- Stocks
- LVRLF Stock
Select your edition
All financial news and data tailored to specific country editions
















